Dissolution Testing For Bioequivalence

Dissolution Testing for Bioequivalence is a pharmaceutical analytical method that evaluates the rate and extent of drug release from a dosage form under standardized conditions to establish in vitro equivalence as a surrogate for in vivo bioequivalence in regulatory approval of generic drug products.

116

Publications

3.4K

Citations

503

Authors

174

Institutions

Publications per year

2017–2026

41

Authors

503

  1. AG
    Alfredo García‐Arieta

    Agencia Española de Medicamentos y Productos Sanitarios, Spain

    9 publications · 281 citations

    9

    h-index

  2. MB
    Marival Bermejo

    Universitat de Miguel Hernández d'Elx, Spain

    6 publications · 141 citations

    7

    h-index

  3. IG
    Isabel González‐Álvarez

    Universitat de Miguel Hernández d'Elx, Spain

    5 publications · 122 citations

    6

    h-index

  4. MG
    Marta González‐Álvarez

    Universitat de València, Spain

    5 publications · 122 citations

    5

    h-index

  5. VP
    Vinod P. Shah

    Center for Drug Evaluation and Research, United States

    5 publications · 255 citations

    5

    h-index

1–5 of 503

Venues

  1. Dissolution Technologies

    16 publications · 564 citations

    13

    h-index

  2. The AAPS Journal

    AAPSJ · 7 publications · 387 citations

    8

    h-index

  3. Pharmaceutics

    6 publications · 110 citations

    8

    h-index

  4. Molecular Pharmaceutics

    5 publications · 135 citations

    6

    h-index

  5. PubMed

    Repository · 5 publications · 118 citations

    5

    h-index

1–5